• Lilly forms up to $1bn drug discovery alliance with Anima Biotech pharmaceutical-technology
    July 26, 2018
    Eli Lilly has signed an agreement with therapeutics company Anima Biotech to discover and develop translation inhibitor drugs for proteins related to a variety of difficult-to-treat diseases.
  • Anima Biotech Announces Collaboration with Lilly americanpharmaceuticalreview
    July 24, 2018
    Anima Biotech announced an agreement with Lilly for the discovery and development of translation inhibitors for several target proteins by using Anima's Translation Control Therapeutics platform.
PharmaSources Customer Service